Cargando…

Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Maw, M K, Fujimoto, J, Tamaya, T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720194/ http://dx.doi.org/10.1038/sj.bjc.6605205

Ejemplares similares

Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers
por: Maw, M K, et al.
Publicado: (2008)

Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers
por: Maw, Min Khine, et al.
Publicado: (2009)

Relatively High Expression Ratio of Sex Hormone‐binding Globulin Exon VII Splicing Variant to Wild‐type mRNA in Human Uterine Cervical Cancers
por: Misao, Ryou, et al.
Publicado: (1998)

Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers
por: Fujimoto, J, et al.
Publicado: (1999)

Expression of IP-10 related to angiogenesis in uterine cervical cancers
por: Sato, E, et al.
Publicado: (2007)

Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers
por: Jahan, Israt, et al.
Publicado: (2008)

Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers
por: Fujimoto, J, et al.
Publicado: (1999)

Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers
por: Fujimoto, J, et al.
Publicado: (2004)

Corrigendum to “SIRT1 Inhibition Affects Angiogenic Properties of Human MSCs”
por: Botti, Chiara, et al.
Publicado: (2015)

Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
por: Alam, S M, et al.
Publicado: (2008)

Corrigendum to: Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study
Publicado: (2016)

Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors
Publicado: (2022)

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
por: Infante, Jeffrey R, et al.
Publicado: (2018)

Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: Jie, Li-Gang, et al.
Publicado: (2022)

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
por: Shroff, Rachna T, et al.
Publicado: (2018)

Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer
por: Soh, C-L, et al.
Publicado: (2015)

Objective assessment of tumour response to therapy based on tumour growth kinetics
por: Mehrara, E, et al.
Publicado: (2011)

Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide
por: Cebon, J, et al.
Publicado: (2007)

Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain
por: Galvão, Teca Calcagno, et al.
Publicado: (2006)

Corrigendum: Genetic correction of Werner syndrome gene reveals impaired pro‐angiogenic function and HGF insufficiency in mesenchymal stem cells
por: Tu, Jiajie, et al.
Publicado: (2020)

Corrigendum to: The DNA intercalators ethidium bromide and propidium iodide also bind to core histones
Publicado: (2022)

Correction to ‘Binding of DNA origami to lipids: maximizing yield and switching via strand displacement’
por: Singh, Jasleen Kaur Daljit, et al.
Publicado: (2021)

Corrigendum to “A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm)” [ID Cases 21 (2020) e00829]
por: Chettri, Shabnam, et al.
Publicado: (2020)

Corrigendum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment
Publicado: (2022)

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum]
Publicado: (2019)

Correction to ‘Molecular structure, DNA binding mode, photophysical properties and recommendations for use of SYBR Gold’
por: Kolbeck, Pauline J, et al.
Publicado: (2021)

5-Formylcytosine mediated DNA–protein cross-links block DNA replication and induce mutations in human cells
por: Ji, Shaofei, et al.
Publicado: (2018)

Phage T7 DNA mimic protein Ocr is a potent inhibitor of BREX defence
por: Isaev, Artem, et al.
Publicado: (2020)

Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage
por: Josephs, Eric A., et al.
Publicado: (2016)

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells
por: Morimoto, Y, et al.
Publicado: (2004)

Endothelial FAK is required for tumour angiogenesis
por: Tavora, Bernardo, et al.
Publicado: (2016)

Corrigendum to “Prediction of Endometrial Hyperplasia and Cancer among Premenopausal Women with Abnormal Uterine Bleeding”
por: Giannella, Luca, et al.
Publicado: (2020)

Phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage
por: Munoz, Ivan M., et al.
Publicado: (2017)

DNA binds to a specific site of the adhesive blood-protein von Willebrand factor guided by electrostatic interactions
por: Sandoval-Pérez, Angélica, et al.
Publicado: (2020)

Hyperglycemia exacerbates dengue virus infection by facilitating poly(A)-binding protein–mediated viral translation
por: Shen, Ting-Jing, et al.
Publicado: (2023)

The histone deacetylase inhibitor trichostatin A alters the pattern of DNA replication origin activity in human cells
por: Kemp, Michael G., et al.
Publicado: (2005)

Corrigendum to “Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ERα in Mice”
por: Lai, Luju, et al.
Publicado: (2020)

[Corrigendum] Human papillomavirus E6‑regulated microRNA‑20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2
por: Cheng, Yuan, et al.
Publicado: (2023)

Corrigendum: Proportion of Uterine Malignant Tumors in Patients with Laparoscopic Myomectomy: A National Multicenter Study in China
Publicado: (2018)

Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
por: Rabe, Thomas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4efa4ljiaqartuqor80afpg5fu